It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Treatment Study for Articular Cartilage Injuries in the Knee

Clinical Trial Title: 
A randomized comparison of NeoCart to microfracture for the repair of articular cartilage injuries in the knee: Phase III / confirmatory study.
Clinical Trial Protocol ID: 
15052903
Clinical Trial Investigator Name: 
Brian J. Cole, MD, MBA
Clinical Trial Protocol Description: 

The purpose of this company-sponsored Phase 3 study is to learn about the safety and potential efficacy of the investigational cartilage tissue implant, NeoCart®, compared to microfracture, the current standard of care surgery for articular cartilage defects of the knee. A total of 245 patients will participate in the NeoCart clinical trial in up to 40 sites across the United States.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are able and willing to give informed consent.
  • Are 18 to 59 years of age.
  • Are symptomatic with knee pain indicative of an articular cartilage injury of the distal femur and/or trochlea.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Orthopedic Conditions
Contact Phone: 
(773) 257-7057
Contact Name: 
Knee 1